前体B细胞急性淋巴细胞白血病:全球视角
本文以青少年前体B细胞急性淋巴细胞白血病为例,邀请全球五家机构专家描述各自管理方案与理由,涵盖低至高收入国家在诊断、治疗和随访中的不同挑战,并由领域专家比较这些管理模式的优劣与局限。
要点
- 血液科实践需遵循标准化指南,但治疗无法完全照搬固定方案。
- 不同机构与国家在相同起始条件下对同一疾病采取不同治疗。
- 全球五家机构专家分别阐述前体B细胞急性淋巴细胞白血病管理方案。
核心结论
- 同一疾病在相同起始条件下,患者会因所在机构和国家的不同而接受不同治疗。
研究设计与样本
- 本文邀请全球五家机构的专家描述其对特定疾病表现的管理计划与理由,并由领域专家总结比较。
主要发现
- 专家们探讨了全球五家机构对前体B细胞急性淋巴细胞白血病的管理,重点关注经济状况较紧张或较宽裕的地区。
- 专家总结比较了这些不同管理风格,并考虑了其优点与局限性。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
As haematologists, we always seek to follow standardised guidelines for practice and apply the best treatment within our means for our patients with blood diseases. However, treatment can never follow an exact recipe. Opinions differ as to the best approach; sometimes more than one treatment approach results in identical outcomes, or treatments differ only by the manner in which they fail. Furthermore, the haematologist is faced with constraints relating to the local economic environment. Patients too are not the same the world over. Early presentation is commoner in the developed world, as is the patient's understanding of the disease process. This in turn has an impact on the way patients are managed, the rigorousness of patient adhesion to the treatment schedule and the outcome. Here we take a look at the precursor B-cell acute lymphoblastic leukaemia in an adolescent in a range of different settings from low- to high income countries with widely differing challenges for diagnosis, therpy and follow-up. For these reasons, given the same starting conditions, patients will be treated differently according to the institute and the country they are in. Experts from around the world have been tasked to describe their management plan and rationale for a specific disease presentation. Here they explore the management of precursor B-cell acute lymphoblastic leukaemia (pre-B ALL) in five different institutions worldwide with a focus on those with more or less strained economies. We end with a conclusion from an expert in the field comparing and contrasting these different management styles and considering their merits and limitations.
引用
- Biondi A, Conter V, Chandy M, et al. Precursor B-cell acute lymphoblastic leukaemia-a global view. Br J Haematol. 2021. PMID: 34931311. doi:10.1111/bjh.17959
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。